Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Thera on twitter with the KEY...
View:
Post by TH1902 on Oct 02, 2022 1:41pm

Thera on twitter with the KEY...

https://twitter.com/Theratech_/status/1575188642175369216?s=20&t=QS8afHeKpFBSgstkF5qaLw
Comment by longterm56 on Oct 02, 2022 2:01pm
Interesting. At first I thought this quote was an "overstatement" by an enthisiastic CEO in front of the public, but if that was the case they would not have continued to publicize it, would they?     -LT
Comment by qwerty22 on Oct 02, 2022 3:57pm
I guess you could say this is based on preclinical and Ph1a but with 1b running if they aren't sitting on something that is either a solid, decent responder number or looks odds on to convert into that in the near future then I don't know what...... Given he hasn't shut up. It's time to put up Paul!
Comment by palinc2000 on Oct 02, 2022 5:24pm
The statement by itself means absolutely nothing because it is missing the following '´and we are in the midst of conducting a Phase 1 b Clinical Trial in humans to prove that Concept" However personnally  I would not have posted that statement unless I had seen some results in humans resembling some of the  spectacular results in the pre clinical study .That would be ...more  
Comment by PWIB123 on Oct 02, 2022 10:38pm
Nah, I don't think so.  Maybe, but in the context of how THTX has communicated in the past and the point in time with which the statement is being made, it's highly unlikely.  I think they want the investment community to know they have something, but aren't quite ready to articulate exactly how it is the key.  
Comment by Wino115 on Oct 02, 2022 11:46pm
Recalling some of the original discussion around what kind of therapy they were hoping for, a lot revolved around the idea that their PDC internalized really quickly into the tumor cell via SORT1 and, because of that, it fooled MDC-1 reflux resistance, so got to work killing the cell where other drugs didn't.  So  1) rapid internalization & 2) gets by resistance.  That is a  ...more  
Comment by palinc2000 on Oct 03, 2022 9:14am
Only my friend Donald Trump has the power of "thinking" about something and its done like he did when he declassified top secret documents. Unfortunately Paul does not posess that God given power and we will have to be a little more patient to find out if they find the key
Comment by Bucknelly21 on Oct 03, 2022 10:13am
Paul is gods gift to thera...
Comment by Bucknelly21 on Oct 03, 2022 10:20am
Ready for the sell off? When these zip head traders realize that they were wrong about whatever it is they thought would happen. Meanwhile the brilliant marketing team at thtx didnt take advantage of having some fresh eyes on the company. 
Comment by qwerty22 on Oct 03, 2022 11:10am
So presumably the FDA meet today. Then they contact TH or Taimed? I forget who is the lead on this. Then TH/Taimed release the news when? And it falls flat unless the zip heads go crazy??? BTW is there any chance Mr hairdo isn't behind this and say rumours of responders are driving the increased volume and are the evidence of the "key"?  
Comment by Wino115 on Oct 03, 2022 11:02am
I get it, but let's work from the premise that Paul knows a whole lot more than we do and he's likely far more adept at connecting some of the disparate datapoints coming out of the trial with the help of Marsolais, Belivieu, Rothemberg, Cancer Advisory Panel. We don't know, but he knows what the 24/48 hr plasma readings showed, what the pace of efficacy vs SAEs was at each reading ...more  
Comment by qwerty22 on Oct 03, 2022 11:31am
You could argue that just because the trial is still ongoing is proof enough they "think" they have the "key". If they didn't think they had the key the trials would stop. This is the problem with these statements you can go around in circles convincing yourself they do or don't have special meaning. Maybe they are less about what Paul thinks and just there to get other ...more  
Comment by palinc2000 on Oct 03, 2022 11:45am
I think we are thinking the same!!! As I wrote I would not have written the statement about the key if I did not have fairly strong evidence of efficacy but I think we should all be prudent in interpreting what was said....Placing over reliance on the statement is  setting up for disappointment ,,....While we dont know much about the trial we should expect only  a minority of patients in ...more  
Comment by palinc2000 on Oct 03, 2022 11:53am
First come first served cannot be adapted to mean First Come First Cured is what I am saying  
Comment by jfm1330 on Oct 03, 2022 11:56am
The key to bypass the cellular menmbrane efflux pump is the way sortilin is internalized. That is through endosomes that protect the PDC since it is not free, it is still integrated in the endosome's membrane. Then, this endosome can fuse with other endosomes or with membranes of the Golgi apparatus or endoplasmic reticulum. Ultimately the PDC will be released and cleaved, generating free ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities